AS-IV has also been shown to hinder the migration and infiltration of cells and suppress the progression of HCC and NSCLC by blocking the stimulation of the Akt/GSK-3β/β-catenin pathway. The gene discussed is GSK3B; the disease is non-small cell lung carcinoma.